Did you mean acetaminophen of aspirina and non ibuprofen?
Displaying drugs 14301 - 14325 of 14792 in total
Setrobuvir
Setrobuvir has been used in trials studying the treatment of Hepatitis C, Chronic.
Investigational
Matched Description: … Setrobuvir has been used in trials studying the treatment of Hepatitis C, Chronic. …
Perfluoro tert-butylcyclohexane
Oxycyte has been used in trials studying the treatment of Traumatic Brain Injury.
Investigational
Matched Description: … Oxycyte has been used in trials studying the treatment of Traumatic Brain Injury. …
Tedatioxetine
Tedatioxetine has been used in trials studying the treatment of Major Depressive Disorder.
Investigational
Matched Description: … Tedatioxetine has been used in trials studying the treatment of Major Depressive Disorder. …
GSI-136
GSI-136 has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Description: … GSI-136 has been used in trials studying the treatment of Alzheimer Disease. …
AZD-7325
AZD7325 is a high affinity, selective modulator of the GABAA receptor system.
Investigational
Matched Description: … AZD7325 is a high affinity, selective modulator of the GABAA receptor system. [L2936] …
TNG908
TNG908 is a small molecule inhibitor of protein arginine methyl transferase 5 (PRMT5).
Investigational
Matched Description: … TNG908 is a small molecule inhibitor of protein arginine methyl transferase 5 (PRMT5). …
Ifidancitinib
Ifidancitinib is under investigation in clinical trial NCT03585296 (A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis).
Investigational
Matched Description: … for the Treatment of Atopic Dermatitis). ... Ifidancitinib is under investigation in clinical trial NCT03585296 (A Study of ATI-502 Topical Solution …
Napabucasin
Napabucasin has been investigated for the treatment of Colorectal Carcinoma.
Investigational
Matched Description: … Napabucasin has been investigated for the treatment of Colorectal Carcinoma. …
Cerlapirdine
Cerlapirdine has been investigated for the treatment of Alzheimer Disease.
Investigational
Matched Description: … Cerlapirdine has been investigated for the treatment of Alzheimer Disease. …
Patidegib
Patidegib has been investigated for the treatment of Conventional Chondrosarcoma.
Investigational
Matched Description: … Patidegib has been investigated for the treatment of Conventional Chondrosarcoma. …
Saroglitazar
Saroglitazar has been investigated for the treatment of Fatty Liver.
Investigational
Matched Description: … Saroglitazar has been investigated for the treatment of Fatty Liver. …
Vamifeport
Vamifeport is being investigated for the treatment of beta-thalassemia.
Investigational
Matched Description: … Vamifeport is being investigated for the treatment of beta-thalassemia. …
Pipequaline
Pipequaline is an anticonflict & anticonvulsant quinoline derivative. It is an anxiolytic drug that was never marketed. It presents a unique chemical structure that does not follow the structural properties of other drugs of its class. Pipequaline has a similar pharmacological profile to the reported for the benzodiazepines. However, it...
Experimental
Matched Description: … of its class. ... It presents a unique chemical structure that does not follow the structural properties of other drugs ... However, it presents a significant set of anxiolytic properties with a very little sedative, amnestic …
Valomaciclovir stearate
Valomaciclovir stearate is under investigation in clinical trial NCT00831103 (A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster).
Investigational
Matched Description: … -348 for the Treatment of Herpes Zoster). ... Valomaciclovir stearate is under investigation in clinical trial NCT00831103 (A Phase 2b Trial of EPB …
Ragaglitazar
Investigational
2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID
Experimental
PF-00446687
PF-00446687 has been investigated for the treatment of Erectile Dysfunction.
Investigational
Matched Description: … PF-00446687 has been investigated for the treatment of Erectile Dysfunction. …
Tetrazepam
Experimental
DNB-001
DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed for the treatment of glaucoma. In preclinical animal models, DNB-001 has demonstrated potent IOP- lowering effects as well as neuroprotective effects on the optic nerve.
Investigational
Matched Description: … for the treatment of glaucoma. ... DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed …
Displaying drugs 14301 - 14325 of 14792 in total